Jatt Acquisition Corp Cl A (JATT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JATT | CLLS | MOLN | ||
| Company | Jatt Acquisition Corp Cl A | Cellectis S.A. ADR | Molecular Partners Ag ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 10.38 | 2.70 | 3.88 | ||
| High | 10.51 | 3.01 | 4.03 | ||
| Low | 7.80 | 2.64 | 3.77 | ||
| Last | 8.16 | 2.99 | 3.77 | ||
| Change | -2.59 | +0.45 | -0.10 | ||
| % Change | -24.09% | +17.90% | -2.71% | ||
| Volume | 88,500 | 299,700 | 16,900 | ||
| 20-Day Average Volume | 46,075 | 52,225 | 6,455 | ||
| Previous Close | 10.75 | 2.54 | 3.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.22 | 2.62 | 3.89 | ||
| 20-Day Raw Stochastic | 7.86% | 97.20% | 28.16% | ||
| 20-Day Relative Strength | 27.48% | 62.21% | 45.70% | ||
| Weighted Alpha | -20.21 | -29.39 | -46.00 | ||
| Today's Opinion | 8% Buy | 72% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 32% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.11% since 03/13/23 | +20.08% since 04/25/24 | -2.96% since 04/22/24 | ||
| Low | 7.80 on 03/20/23 | 2.35 on 04/26/24 | 3.60 on 05/01/24 | ||
| High | 12.38 on 03/16/23 | 3.01 on 05/02/24 | 4.27 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -21.91% since 02/15/23 | +12.83% since 04/02/24 | -3.46% since 04/02/24 | ||
| Low | 7.80 on 03/20/23 | 2.30 on 04/18/24 | 3.32 on 04/19/24 | ||
| High | 12.38 on 03/16/23 | 3.01 on 05/02/24 | 4.90 on 04/12/24 | ||
| 3-Month | |||||
| %Chg | -20.00% since 12/13/22 | +1.36% since 02/02/24 | -22.05% since 02/01/24 | ||
| Low | 7.80 on 03/20/23 | 2.30 on 04/18/24 | 3.32 on 04/19/24 | ||
| High | 12.38 on 03/16/23 | 3.13 on 02/08/24 | 4.94 on 02/06/24 | ||
| 6-Month | |||||
| %Chg | -18.73% since 09/20/22 | -0.66% since 11/02/23 | -9.93% since 11/02/23 | ||
| Low | 7.80 on 03/20/23 | 2.30 on 04/18/24 | 3.32 on 04/19/24 | ||
| High | 12.38 on 03/16/23 | 3.77 on 12/20/23 | 5.08 on 01/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 140,760 | 140,961 | 140,748 | ||
| Shares Outstanding, K | 17,250 | 55,584 | 36,369 | ||
| Annual Sales | 0 | 25,730,000 | 7,840,000 | ||
| Annual Net Income | 6,850,000 | -106,140,000 | -69,040,000 | ||
| Last Quarter Sales | 0 | 1,640,000 | 1,210,000 | ||
| Last Quarter Net Income | 458,470 | -17,480,000 | -22,340,000 | ||
| 60-Month Beta | 0.00 | 3.08 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.64 on 04/29/24 | -0.68 on 03/14/24 | ||
| Latest Earnings Date | N/A | 05/02/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||